US › Healthcare

Psyence Biomedical Ltd. Common Shares (PBM)

US · Healthcare · Biotechnology

$6.32+8.59%

Last close · 2026-09-17

Latest quarter · ended 2025-09-30

Revenue

Net profit

$-753,254

EPS

$-0.51

EPS estimate

$0.00

Key statistics

Market cap

$22.9M

Forward P/E

0.0

P/B

1.22

Book value

$7.39

EPS (TTM)

$-12.56

52-week high

$34.62

52-week low

$1.92

50-day MA

$3.68

200-day MA

$11.42

Beta

1.73

Shareholding

Insiders

2.97%

Institutions

9.72%

Largest institutional holders

Fund	Stake
Parallel Advisors, LLC	3.97%
AdvisorShares Investments, LLC	3.20%
Stonehage Fleming Financial Services Holdings Ltd	0.00%
Bank of America Corp	0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Psyence Biomedical Ltd. Common Shares — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.